{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T10:53:31Z","timestamp":1778756011390,"version":"3.51.4"},"reference-count":29,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":3603,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1038\/modpathol.2012.168","type":"journal-article","created":{"date-parts":[[2012,10,11]],"date-time":"2012-10-11T06:26:16Z","timestamp":1349936776000},"page":"414-420","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"title":["Immunohistochemistry with a mutation-specific monoclonal antibody as a screening tool for the BRAFV600E mutational status in primary cutaneous malignant melanoma"],"prefix":"10.1016","volume":"26","author":[{"given":"John K","family":"Feller","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meera","family":"Mahalingam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1038\/modpathol.2012.168_bib1","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S0092-8674(04)00215-6","article-title":"Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF","volume":"116","author":"Wan","year":"2004","journal-title":"Cell"},{"key":"10.1038\/modpathol.2012.168_bib2","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.cell.2007.12.032","article-title":"Oncogenic BRAF induces senescence and apoptosis through pathways mediated by the secreted protein IGFBP7","volume":"132","author":"Wajapeyee","year":"2008","journal-title":"Cell"},{"key":"10.1038\/modpathol.2012.168_bib3","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00401-011-0841-z","article-title":"Assessment of BRAF V600E mutation status by immunohistochemistry with a mutation-specific monoclonal antibody","volume":"122","author":"Capper","year":"2011","journal-title":"Acta Neuropathol"},{"key":"10.1038\/modpathol.2012.168_bib4","first-page":"6451","article-title":"Similarity of the phenotypic patterns associated with BRAF KRAS mutations in colorectal neoplasia","volume":"62","author":"Yuen","year":"2002","journal-title":"Cancer Res"},{"key":"10.1038\/modpathol.2012.168_bib5","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1093\/jnci\/95.8.625","article-title":"BRAF mutation in papillary thyroid carcinoma","volume":"95","author":"Cohen","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"10.1038\/modpathol.2012.168_bib6","first-page":"1454","article-title":"High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET\/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma","volume":"63","author":"Kimura","year":"2003","journal-title":"Cancer Res"},{"key":"10.1038\/modpathol.2012.168_bib7","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.humpath.2009.12.002","article-title":"Oncogenic BRAF-positive dysplastic nevi and the tumor suppressor IGFBP7\u2014challenging the concept of dysplastic nevi as precursor lesions?","volume":"41","author":"DeCarlo","year":"2010","journal-title":"Hum Pathol"},{"key":"10.1038\/modpathol.2012.168_bib8","first-page":"1","article-title":"RASRAF mutations in banal melanocytic aggregates contiguous with primary cutaneous melanoma: clues to melanomagenesis","author":"Dadzie","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1038\/modpathol.2012.168_bib9","first-page":"1","article-title":"Mixed versus pure variants of desmoplastic melanoma: a genetic and immunohistochemical appraisal","author":"Miller","year":"2011","journal-title":"Mod Pathol"},{"key":"10.1038\/modpathol.2012.168_bib10","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/sj.bjc.6606030","article-title":"Targeting BRAF for patients with melanoma","volume":"104","author":"Arkenau","year":"2011","journal-title":"Br J Cancer"},{"key":"10.1038\/modpathol.2012.168_bib11","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1158\/1078-0432.CCR-1169-3","article-title":"Incidence of BRAF oncogene mutation and clinical relevance for primary cutaneous melanomas","volume":"10","author":"Shinozaki","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1038\/modpathol.2012.168_bib12","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1200\/JCO.2010.32.4327","article-title":"Prognostic and clinicopathologic associations of oncogenic BRAF in metastatic melanoma","volume":"29","author":"Long","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1038\/modpathol.2012.168_bib13","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1210\/jc.2009-0247","article-title":"Molecular testing for mutations in improving the fine-needle aspiration diagnosis of thyroid nodules","volume":"94","author":"Nikiforova","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1038\/modpathol.2012.168_bib14","doi-asserted-by":"crossref","first-page":"569","DOI":"10.5858\/2010-0664-RAIR.1","article-title":"Molecular diagnostics of thyroid tumors","volume":"135","author":"Nikiforova","year":"2011","journal-title":"Arch Pathol Lab Med"},{"key":"10.1038\/modpathol.2012.168_bib15","doi-asserted-by":"crossref","first-page":"5705","DOI":"10.1200\/JCO.2008.18.0786","article-title":"Wild-type BRAF is required for response to panitumumab or cetuximab in metastatic colorectal cancer","volume":"26","author":"Di Nicolantonio","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1038\/modpathol.2012.168_bib16","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1006\/bbrc.2000.2716","article-title":"Melanin binds reversibly to thermostable DNA polymerase and inhibits its activity","volume":"271","author":"Eckhart","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1038\/modpathol.2012.168_bib17","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/ng1054","article-title":"High frequency of BRAF mutations in nevi","volume":"33","author":"Pollock","year":"2003","journal-title":"Nat Genet"},{"key":"10.1038\/modpathol.2012.168_bib18","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1097\/01.pas.0000141404.56839.6a","article-title":"BRAF and KRAS mutations in hyperplastic polyps and serrated adenomas of the colorectum: relationship to histology and CpG island methylation status","volume":"28","author":"Yang","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2012.168_bib19","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1097\/01.pas.0000213313.36306.85","article-title":"Comparison of microsatellite instability, CpG island methylation phenotype, BRAF and KRAS status in serrated polyps and tradtional adenomas indicates separate pathways to distinct colorectal carcinoma end points","volume":"30","author":"O\u2019Brien","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2012.168_bib20","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1158\/0008-5472.CAN-07-3293","article-title":"Oncogene addiction","volume":"68","author":"Weinstein","year":"2008","journal-title":"Cancer Res"},{"key":"10.1038\/modpathol.2012.168_bib21","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1046\/j.0022-202X.2004.22225.x","article-title":"BRAF mutations are common somatic events in melanocytic nevi","volume":"122","author":"Kumar","year":"2004","journal-title":"J Invest Dermatol"},{"key":"10.1038\/modpathol.2012.168_bib22","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1038\/jid.2008.374","article-title":"Frequencies of NRAS and BRAF mutations increase from the radial to the vertical growth phase in cutaneous melanoma","volume":"129","author":"Greene","year":"2009","journal-title":"J Invest Dermatol"},{"key":"10.1038\/modpathol.2012.168_bib23","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1309\/AJCPO3F2ENKMDTUS","article-title":"Detection of BRAF mutations in thyroid nodules by allele-specific PCR using a dual priming oligonucleotide system","volume":"133","author":"Lee","year":"2010","journal-title":"Am J Clin Pathol"},{"key":"10.1038\/modpathol.2012.168_bib24","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/CMR.0b013e32833d8d48","article-title":"An inexpensive specific and highly sensitive protocol to detect the BRAFV600E mutation in melanoma tumor biopsies and blood","volume":"20","author":"Panka","year":"2010","journal-title":"Melanoma Res"},{"key":"10.1038\/modpathol.2012.168_bib25","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/j.1600-0560.2009.01248.x","article-title":"Cutaneous sebaceous neoplasms as markers of Muir-Torre syndrome: a diagnostic algorithm","volume":"36","author":"Abbas","year":"2009","journal-title":"J Cutan Pathol"},{"key":"10.1038\/modpathol.2012.168_bib26","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/modpathol.3800997","article-title":"MSH-6: extending the reliability of immunohistochemistry as a screening tool in Muir-Torre syndrome","volume":"21","author":"Chhibber","year":"2008","journal-title":"Mod Pathol"},{"key":"10.1038\/modpathol.2012.168_bib27","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00401-011-0887-y","article-title":"Immunohistochemical testing of BRAF V600E status in 1,120 tumor tissue samples of patients with brain metastases","volume":"123","author":"Capper","year":"2012","journal-title":"Acta Neuropathol"},{"key":"10.1038\/modpathol.2012.168_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/PAS.0b013e3182549b50","article-title":"Application of a BRAF V600E mutation-specific antibody for the diagnosis of hairy cell leukemia","volume":"36","author":"Andrulis","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2012.168_bib29","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/onc.2008.362","article-title":"CRAF inhibition induces apoptosis in melanoma cells with non-V600E BRAF mutations","volume":"28","author":"Smalley","year":"2009","journal-title":"Oncogene"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/modpathol2012168.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/modpathol2012168","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089339522203441X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089339522203441X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/modpathol2012168.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T01:10:22Z","timestamp":1760231422000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S089339522203441X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["S089339522203441X"],"URL":"https:\/\/doi.org\/10.1038\/modpathol.2012.168","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.717964094.793474748","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.717964094.793465868","asserted-by":"object"}]},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunohistochemistry with a mutation-specific monoclonal antibody as a screening tool for the BRAFV600E mutational status in primary cutaneous malignant melanoma","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/modpathol.2012.168","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2013 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}